CClinicalTrials.gg
Enrolling by invitationNCT06363526DMDrespy2024Updated Apr 1, 2025

Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.

An interventional study of Digital respiratory intervention program in Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Muscular Dystrophy, sponsored by University of Malaga. Enrolling by invitation at 1 site in Spain. Open to participants aged 5 Years to 20 Years. Per ClinicalTrials.gov, last updated 2025-04-01.

Sponsored by University of Malaga · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 2 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
5 Years to 20 Years
Sex
All
01

Study summary

The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.

Read the detailed description

It will be done 4 times a week for a period of 5 weeks, for a duration of 55-60 minutes (20 sessions), with an intensity adapted to the characteristics of each participant. An intervention program will be used based on respiratory muscle training exercises, upper limb strength work, yoga, diaphragmatic awareness exercises, always trying to do them through the use of games, and even try to include exercises that use motor imagery.

It is advisable during intervention program to have a playful environment stimulated for the children, and that the intervention program is carried out and stimulated through videos and therapeutic teaching to the caregivers in the first evaluation session, as well as with a weekly follow-up using WhatsApp as forms of communication, or a telephone call to ensure correct follow-up of the intervention program.

It is essential that to carry out the intervention, videos obtained from YouTube, own videos prepared to explain the exercises in a playful way applied to children, and even other applications such as Spotify to work with music, will be used, being offered in case of Zoom calls may be necessary to help optimally resolve doubts that arise when carrying out the program by video call.

At the end of the respiratory digital physiotherapy program, variables will be evaluated by the principal examiner.

02

Conditions studied

  • Duchenne Muscular Dystrophy
  • Becker Muscular Dystrophy
  • Muscular Dystrophy

Keywords

  • Duchenne Muscular Dystrophy
  • Becker Muscular Dystrophy
  • Breathing exercises
  • Inspiratory muscle training
  • Pulmonary rehabilitation
  • Expiratory muscle training
03

In context

Muscular Dystrophies

548 studies on the registry are indexed under Muscular Dystrophies; 89 are open to participants now.

This study's planned enrollment of 12 is below the median of 24 across 344 interventional studies indexed under Muscular Dystrophies.

Browse Muscular Dystrophies studies →

Lead sponsor

University of Malaga is the lead sponsor of 118 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants with Duchenne muscular dystrophy and patients with Becker muscular dystrophy will be chosen.
  • Aged between 5 and 20 years.
  • Child who could walk and follow the intervention program, and were diagnosed according to the International Classification of Diseases, 10 Revision. code (G71-01); and who had an NSSA score greater than 20.

Exclusion criteria

Exclusion Criteria:

  • Patients who present associated heart disease.
  • Patients who presentor fractures, a heart rate greater than 120 beats per minute, or an oxygen saturation less than 89% will be excluded.
  • Participants who do not have the capacity to have internet at home to perform the intervention, as well as all patients whose caregivers did not agree to sign the informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Patients with Duchenne muscular dystrophy and Becker muscular dystrophy

    A group of 12 patients with Duchenne muscular dystrophy and Becker muscular dystrophy that will be following a digital respiratory physiotherapy program.

    Other: Digital respiratory intervention program

Interventions

  • OtherDigital respiratory intervention program

    A 4 times a week for a period of 5 weeks will be done, for a duration of 55-60 minutes (20 sessions), with an intensity adapted to the characteristics of each participant. Moreover, an intervention program will be used based on respiratory muscle training exercises, upper limb strength work, yoga, diaphragmatic awareness exercises, always trying to do them through the use of games, and even try to include exercises that use motor imagery. The intervention program is carried out and stimulated through videos and therapeutic teaching to the caregivers in the first evaluation session, as well as as well as with a weekly follow-up using WhatsApp or Zoom as forms of communication, or a telephone call to ensure correct follow-up of the intervention program. Moreover, YouTube videos, own videos prepared by the physiotherapy will be used to help optimally resolve doubts that arise when carrying out the program by video call.

06

What researchers measure

Primary outcomes

  1. Analyze the improvement of the forced vital capacity (FVC).

    Forced vital capacity is a respiratory parameter which is obtained from spirometry and which provides objective, valid information. It will be performed using spirometry before and after the digital respiratory intervention program. The spirometer that will be used is the "EasyOne Air Spirometer that complies with ISO 26782 standards, following the national spirometric recommendations of the ATS/ERS 2019.

    Time frame: Baseline, up to 5 weeks.

Secondary outcomes

  1. Perform an anthropometric study of the patient's characteristics, taking into account weight; and also a general physical examination.

    An anthropometric study of the patient's characteristics will be carried out, taking into account age, weight, as well as the average values that should be established based on age; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program. The weight will be check by "SECA 700 MECHANICAL COLUMN SCALE WITH SECA 220 STADIOMETER", and the height will be analyze by a measuring tape.

    Time frame: Baseline, up to 5 weeks.

  2. Perform an anthropometric study of the patient's characteristics, taking into account age.

    An anthropometric study of the patient's characteristics will be carried out, taking into account age, as well as the average values that should be established based on age; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program.

    Time frame: Baseline, up to 5 weeks.

  3. Perform an anthropometric study of the patient's characteristics, taking into account height.

    An anthropometric study of the patient's characteristics will be carried out, taking into account height, as well as the average values that should be established based on age; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program.

    Time frame: Baseline, up to 5 weeks.

  4. Perform an anthropometric study of the patient's characteristics, taking into account sex.

    An anthropometric study of the patient's characteristics will be carried out, taking into account height, as well as the average values that should be established based on sex; as well as a general physical examination of the patient to analyze if they will be considered fit or not to carry out the program.

    Time frame: Baseline, up to 5 weeks.

  5. Examine changes in forced expiratory pressure

    Forced expiratory pressure is a respiratory parameter obtained through spirometry, which provides important information about the patient's respiratory status. Measuring it will be done with the same characteristics as that previously mentioned in the FVC.

    Time frame: Baseline, up to 5 weeks.

  6. Analyze changes in maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP).

    Changes in the strength of the inspiratory and expiratory muscles will be assessed using a pressure meter with a reading range of ±300 cm H20 and an accuracy of 3% (MicroRPM® model, Vyaire Medical GmbH, Hoechberg, Germany) following the national recommendations of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) (16).

    Time frame: Baseline, up to 5 weeks.

  7. Check if there are changes in the sniff nasal inspiratory pressure (SNIP)

    The existence of changes in the diaphragm force index is assessed, measuring it in exactly the same way as the MIP and PEM.

    Time frame: Baseline, up to 5 weeks.

  8. Evaluate the fatigue in patients using an EPInfant test.

    The amount of effort the child perceives during the sessions is assessed. It shows 11 descriptors numbered from 0 to 10 and 5 verbal descriptors located every 2 levels of the numbered descriptors, along with a drawing of a child doing physical activity in an increasing manner, increasing in intensity from left to right. The higher the numerical value, the worse the result is considered.

    Time frame: Baseline, up to 5 weeks.

  9. Evaluate the quality of life of patients using a scale called "Kindscreen-52".

    52-item scale carried out in Ravens-Sieberer U and validated in Spanish by Rajmil L, which assesses physical and psychological well-being, mood and emotions, self-perception, autonomy and relationship with friends and social life. . The scores were transformed into a scale from 0 to 100 to facilitate their interpretation: the higher the score, the higher HRQoL.

    Time frame: Baseline, up to 5 weeks.

  10. North Star Ambulatory Assessment o NSAA

    Designed to capture the construct of ambulatory function in DMD. 17-item scale that grades performance of various functional skills on a scale from 0 (unable), 1 (completes independently but with modifications), and 2 (completed without compensation). Total score 0 - 34 with a higher score denoting a higher level of function. It includes two timed tests. Timed rise from floor (RFF) and timed 10 metre walk / run test (10MWR). Validated and regularly used in clinical trials as well as clinic. Well understood by families. The best score is 34 points.

    Time frame: Baseline, up to 5 weeks.

07

Study locations

1 site
  • Rocío Martín-Valero
    Málaga, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06363526
Lead sponsor
University of Malaga
Responsible party
Rocío Martín Valero (Principal Investigator, University of Malaga) — Principal investigator
First posted
Apr 12, 2024
Start date
Feb 5, 2025
Primary completion
Jul 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Apr 1, 2025

Study contacts

Rocío Martín-Valero, PhD
study director · University of Malaga

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion